Browsing: MRD

Listen to the article 8 min This audio is auto-generated. Please let us know if you have feedback. Molecular residual…

Transaction extends CareDx’s Precision Medicine Testing Services strategy into specialty oncology with a Medicare-reimbursed commercial-stage MRD test and platform addressing…

What You Should Know CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in…

What You Should Know:  – Adaptive Biotechnologies Corporation and Flatiron Health today announced the integration of Adaptive’s clonoSEQ® test for…